| CANDRIAM EQUITIES L BIOTECHNOLOGY, C-H - CAPITALISATION |
    
|
|
| DAX | 25.238,14 | 349,58 | 1,40% |
| TecDax | 4.064,36 | 28,27 | 0,70% |
| MDAX | 32.789,76 | 681,49 | 2,12% |
| Dow Jones (EOD) | 50.579,70 | 294,04 | 0,58% |
| Nasdaq 100 | 29.481,64 | 124,37 | 0,42% |
| S & P 500 (EOD) | 7.473,47 | 27,75 | 0,37% |
| SMI | 13.503,21 | 56,78 | 0,42% |
|
| EUR/US$ | 1,1643 | 0,00 | 0,34% |
| EUR/Yen | 185,0440 | 0,33 | 0,18% |
| EUR/CHF | 0,9099 | -0,00 | -0,11% |
| EUR/Brit. Pfund | 0,8629 | -0,00 | -0,09% |
| Yen/US$ | 0,0063 | 0,00 | 0,02% |
| CHF/US$ | 1,2795 | 0,00 | 0,10% |
|
| baha Brent Indication | 95,11 | -5,63 | -5,59% |
| Gold | 4.569,11 | 60,82 | 1,35% |
| Silber | 78,07 | 2,54 | 3,37% |
| Platin | 1.952,40 | 22,04 | 1,14% |
| |
|
|
273,70 
